Inovio Pharmaceuticals, Inc.

Good afternoon and welcome to the Inovio Pharmaceuticals first quarter 2022 financial results conference call. All participants will be in a listen-only mode. Should you need assistance, please signal conference specialists by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on your telephone keypad. To withdraw your question, please press star then two. Please note this event is being recorded. I would now like to turn the conference over to Ben Mattone, Senior Director of Investor Relations. Please go ahead.

Thank you, Operator. Good afternoon, and thank you for joining the Inovio First Quarter 2022 Earnings Conference Call. Joining me on today's call are Dr. Jackie Shea, President and CEO, Mr. Peter Keyes, Chief Financial Officer, Dr. Laurent Hemot, Chief Scientific Officer, Mark Twyman, Chief Commercial Officer, Dr. David Leibowitz, Senior Vice President of Clinical Development for Infectious Diseases, and Dr. Jeffrey Skolnick, Senior Vice President of Clinical Development for Oncology and HPV Therapeutics.

WGU had that special something that I felt was going to give me, again, the most flexibility and the quality of education that I was looking for. Getting this scholarship from WGU gave me the cushion that I needed to go back to school and to pursue this dream. It made all the difference in the world.